--- title: Engineering Efficient CRISPR/Cas Delivery Systems description: Overcoming the barrier to entry is essential for efficient gene-editing using the CRISPR/Cas system. image: https://offers.drugdiscoverynews.com/hubfs/DDN_PPL_Multi_Engineering%20Efficient%20CRISPR%20Cas%20Delivery%20Systems/43104_CRISPR-Coralling-Infographic560x292.png --- INFOGRAPHIC # Engineering Efficient CRISPR/Cas Delivery Systems ![43104\_CRISPR-Coralling-Infographic560x292](https://offers.drugdiscoverynews.com/hs-fs/hubfs/DDN_PPL_Multi_Engineering%20Efficient%20CRISPR%20Cas%20Delivery%20Systems/43104_CRISPR-Coralling-Infographic560x292.png?width=560&name=43104_CRISPR-Coralling-Infographic560x292.png)   ![43104\_CRISPR-Coralling-Infographic958x635](https://offers.drugdiscoverynews.com/hubfs/DDN_PPL_Multi_Engineering%20Efficient%20CRISPR%20Cas%20Delivery%20Systems/43104_CRISPR-Coralling-Infographic958x635.png "43104_CRISPR-Coralling-Infographic958x635")   The CRISPR/Cas system is a powerful tool employed by scientists to edit disease-causing genes *in vitro*. The individual components of this system are composed of structural elements that pose a challenge for delivery to target cells. To overcome this barrier to entry, scientists have designed various viral and nonviral methods to improve the efficiency of CRISPR/Cas delivery. Download this infographic from *Drug Discovery News* to learn about the various viral and nonviral methods that scientists use to efficiently deliver CRISPR/Cas to target cells. Supported by [![thermo-fisher-scientific-logo-11530964369n55iig0pja](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Infographics/2018/Immune%20Human%20Cell%20Atlas/thermo-fisher-scientific-logo-11530964369n55iig0pja.png?width=115&name=thermo-fisher-scientific-logo-11530964369n55iig0pja.png)](https://www.thermofisher.com/ca/en/home.html)   [![BPS-Logo](https://offers.drugdiscoverynews.com/hs-fs/hubfs/BPS-Logo.png?width=115&name=BPS-Logo.png)](https://bpsbioscience.com/)[ ![Cellecta Logo Transparent](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Cellecta%20Logo%20Transparent.png?width=115&name=Cellecta%20Logo%20Transparent.png)](https://cellecta.com/?gclid=Cj0KCQiAjJOQBhCkARIsAEKMtO0pOri7-ze6gD7vjZORb5VCMFD16ISa5X_TbCoSom_wcxBQPf62qdEaAjVjEALw_wcB)        [![Share on Facebook](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/FB.png?width=24&name=FB.png)](http://www.facebook.com/share.php?u=https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Dfacebook) [![Share on LinkedIn](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/linkedIn.png?width=24&name=linkedIn.png)](http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Dlinkedin) [![Share on Twitter](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/Twitter.png?width=24&name=Twitter.png)](https://twitter.com/intent/tweet?original_referer=https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&url=https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&source=tweetbutton&text=Engineering%20Efficient%20CRISPR%2FCas%20Delivery%20Systems) [![Share on Email](https://offers.drugdiscoverynews.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/email.png?width=24&name=email.png)](mailto:?subject=Check%20out%20https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Demail%20&body=Check%20out%20https%3A%2F%2Foffers.drugdiscoverynews.com%2Fengineering-efficient-crispr%2Fcas-delivery-systems-infographic-0%3Futm_medium%3Dsocial%26utm_source%3Demail) ![DDN white logo2 - Copy](https://offers.drugdiscoverynews.com/hubfs/DDN%20white%20logo2%20-%20Copy.png "DDN white logo2 - Copy")   Drug Discovery News 1000 N West Street | Wilmington | Delaware | 19801 | US [Email: privacy@drugdiscoverynews.com](mailto:privacy@drugdiscoverynews.com) © 2025 Drug Discovery News. All rights reserved Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.drugdiscoverynews.com/privacy-policy)